
CAS 2460722-04-5
:Formule :C23H25F5N2O4S
InChI :InChI=1S/C23H25F5N2O4S/c1-4-35(33,34)29-20-18(30(12-23(20,27)28)21(31)22(2,3)32)10-13-6-5-7-17(19(13)26)14-8-15(24)11-16(25)9-14/h5-9,11,18,20,29,32H,4,10,12H2,1-3H3/t18-,20+/m0/s1
Code InChI :KVMGAIOTUIGROS-AZUAARDMSA-N
SMILES :CCS(=O)(=O)N[C@@H]1[C@@H](N(CC1(F)F)C(=O)C(C)(C)O)CC2=C(C(=CC=C2)C3=CC(=CC(=C3)F)F)F
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
2 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Oveporexton
CAS :Oveporexton (TAK-861) is an orally active selective orexin type 2 receptor (OX2R) agonist that can activate recombinant OX2R with an EC50 of 2.5 nM, showing approximately 3000-fold selectivity over OX1R (EC50=7500 nM). In mouse tuberomammillary nucleus histaminergic neurons, Oveporexton can cause dose-dependent depolarization with an EC50 of 31.7 nM, and can increase wakefulness after oral administration in mouse and cynomolgus monkey models. Oveporexton can be used in pharmacological mechanism research on orexin OX2R signaling, arousal state regulation, and sleepiness-related animal models.Formule :C23H25F5N2O4SDegré de pureté :99.76%Masse moléculaire :520.51N-[(2S,3R)-4,4-Difluoro-1-(2-hydroxy-2-methyl-1-oxopropyl)-2-[(2,3′,5′-trifluoro[1,1′-biphenyl]-3-yl)methyl]-3-pyrrolidinyl]ethanesulfonamide
CAS :Formule :C23H25F5N2O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :520.5126


